CTMX vs ECL
CytomX Therapeutics Inc (CTMX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CTMX currently screens at market cap $653.1M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CTMX and ECL stock pages for the full models.
Not investment advice.